- Home
- GANX vs BEEM Comparison
GANX vs BEEM Comparison
Compare GANX & BEEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- BEEM
- Stock Information
- Founded
- GANX 2017
- BEEM 2006
- Country
- GANX United States
- BEEM United States
- Employees
- GANX N/A
- BEEM N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- BEEM Semiconductors
- Sector
- GANX Health Care
- BEEM Technology
- Exchange
- GANX Nasdaq
- BEEM Nasdaq
- Market Cap
- GANX 41.9M
- BEEM 49.3M
- IPO Year
- GANX 2021
- BEEM N/A
- Fundamental
- Price
- GANX $2.28
- BEEM $3.03
- Analyst Decision
- GANX Strong Buy
- BEEM Strong Buy
- Analyst Count
- GANX 5
- BEEM 4
- Target Price
- GANX $7.60
- BEEM $9.00
- AVG Volume (30 Days)
- GANX 264.8K
- BEEM 362.7K
- Earning Date
- GANX 11-14-2024
- BEEM 11-14-2024
- Dividend Yield
- GANX N/A
- BEEM N/A
- EPS Growth
- GANX N/A
- BEEM N/A
- EPS
- GANX N/A
- BEEM N/A
- Revenue
- GANX N/A
- BEEM $60,883,000.00
- Revenue This Year
- GANX N/A
- BEEM N/A
- Revenue Next Year
- GANX N/A
- BEEM $24.12
- P/E Ratio
- GANX N/A
- BEEM N/A
- Revenue Growth
- GANX N/A
- BEEM 10.25
- 52 Week Low
- GANX $0.89
- BEEM $2.62
- 52 Week High
- GANX $5.33
- BEEM $8.48
- Technical
- Relative Strength Index (RSI)
- GANX 57.43
- BEEM 43.75
- Support Level
- GANX $2.06
- BEEM $2.92
- Resistance Level
- GANX $2.65
- BEEM $3.31
- Average True Range (ATR)
- GANX 0.29
- BEEM 0.34
- MACD
- GANX 0.01
- BEEM 0.00
- Stochastic Oscillator
- GANX 66.36
- BEEM 10.28
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across, several therapeutics areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. The company derives revenues from collaboration and licensing agreements.
About BEEM Beam Global
Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.